» Articles » PMID: 32917290

Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19

Abstract

We report key epidemiologic parameter estimates for coronavirus disease identified in peer-reviewed publications, preprint articles, and online reports. Range estimates for incubation period were 1.8-6.9 days, serial interval 4.0-7.5 days, and doubling time 2.3-7.4 days. The effective reproductive number varied widely, with reductions attributable to interventions. Case burden and infection fatality ratios increased with patient age. Implementation of combined interventions could reduce cases and delay epidemic peak up to 1 month. These parameters for transmission, disease severity, and intervention effectiveness are critical for guiding policy decisions. Estimates will likely change as new information becomes available.

Citing Articles

Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022-2023 global outbreak.

Diaz Brochero C, Nocua-Baez L, Cortes J, Charniga K, Buitrago-Lopez A, Cucunuba Z BMJ Glob Health. 2025; 10(1).

PMID: 39890207 PMC: 11792283. DOI: 10.1136/bmjgh-2024-016906.


Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.

Garcia-Rodriguez J, Janvier F, Kill C Microorganisms. 2025; 13(1).

PMID: 39858831 PMC: 11767719. DOI: 10.3390/microorganisms13010063.


An analysis of the waning effect of COVID-19 vaccinations.

Lee B, Song H, Apio C, Han K, Park J, Liu Z Genomics Inform. 2024; 21(4):e50.

PMID: 38224717 PMC: 10788359. DOI: 10.5808/gi.23088.


Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.

Xu X, Wu Y, Kummer A, Zhao Y, Hu Z, Wang Y BMC Med. 2023; 21(1):374.

PMID: 37775772 PMC: 10541713. DOI: 10.1186/s12916-023-03070-8.


Model based on COVID-19 evidence to predict and improve pandemic control.

Gonzalez R, Moya P, Bringa E, Bacigalupe G, Ramirez-Santana M, Kiwi M PLoS One. 2023; 18(6):e0286747.

PMID: 37319168 PMC: 10270358. DOI: 10.1371/journal.pone.0286747.


References
1.
Garske T, Legrand J, Donnelly C, Ward H, Cauchemez S, Fraser C . Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009; 339:b2840. DOI: 10.1136/bmj.b2840. View

2.
Kucharski A, Edmunds W . Case fatality rate for Ebola virus disease in west Africa. Lancet. 2014; 384(9950):1260. DOI: 10.1016/S0140-6736(14)61706-2. View

3.
Kraemer M, Yang C, Gutierrez B, Wu C, Klein B, Pigott D . The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020; 368(6490):493-497. PMC: 7146642. DOI: 10.1126/science.abb4218. View

4.
Abbott S, Hellewell J, Munday J, Funk S . The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis. Wellcome Open Res. 2020; 5:17. PMC: 7156988. DOI: 10.12688/wellcomeopenres.15718.1. View

5.
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J . Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020; 25(17). PMC: 7201952. DOI: 10.2807/1560-7917.ES.2020.25.17.2000257. View